Background -Registered mortality from cryptogenic fibrosing alveolitis (CFA) in England and Wales has increased substantially since the specific International Classification of Diseases code for CFA was introduced in 1979. However, since a significant proportion of deaths from CFA are misclassified as post inflammatory fibrosis (PIF), it is possible that the observed rise in CFA mortality is due to diagnostic transfer from this code. To investigate this, and to assess mortality trends in other countries, annual CFA and PIF mortality data from England and Wales, USA, Australia, Scotland, Canada, New Zealand, and Germany were analysed. Methods -Crude annual mortality rates were calculated and rates standardised by Poisson regression to allow assessment of changes over time and comparison between countries, sexes, and age groups. The relative trends in mortality from CFA and PIF were assessed by calculating the annual ratio of CFA to PIF deaths. Results -Men were more likely than women to die from both CFA and PIF in all countries. The highest standardised CFA mortality rate occurred in England and Wales, and the lowest in Germany. Since 1979 mortality from CFA has increased in England and Wales, Australia, Scotland and Canada, but there was no trend in CFA mortality in New Zealand or Germany. In the USA mortality from CFA was low and has fallen. Mortality from PIF increased in all countries except New Zealand and Germany, and the highest PIF mortality, together with the greatest increase over time, was seen in the USA.
Cryptogenic fibrosing alveolitis (CFA) is an interstitial lung disease which, though first recognised in 1935,' did not receive a specific International Classification of Diseases (ICD) code until the ninth ICD revision in 1979. 2 Until 1979 deaths from CFA were included in broader code categories with other diseases such as chronic interstitial pneumonia. In an analysis of CFA mortality data for England and Wales since 1979 we have previously shown that mortality from CFA increased approximately twofold between 1979 and 1988, but that over 40% of deaths coded as post inflammatory fibrosis (PIF) were also likely to be due to CFA.3 It is therefore not clear whether the increase in registered CFA mortality in England and Wales is the result of diagnostic transfer from PIF.
In the present study our objectives were to determine whether mortality from CFA is still increasing in England and Wales, and to establish whether CFA mortality has also increased significantly over time in other countries. We have also inspected the relative trends in CFA and PIF mortality to determine whether these are consistent with a true rise in mortality from these diseases or are more suggestive of diagnostic transfer from PIF to CFA. Mortality rates from CFA and PIF were compared between sexes, countries, and age groups using reported annual mortality data for CFA and PIF in England and Wales, Australia To compare the rates of mortality between sexes, age groups, and countries the number of deaths in each subgroup, together with the relevant denominator populations, were summed for the years that data were available England and Wales  2-326  2-225 to 2-432  <0 001  1 000  Scotland   1-829  1-566 to 2-136  <0 001  0-891  0-823 to 0-965  <0 005  Canada  1-887  1 620 to 2 197  <0 001  0 269  0-249 to 0 291  <0 001  Australia  1 993  1-738 to 2-287  <0-001  0-495  0-462 to 0-531  <0-001  New Zealand  1 965  1-403 to 2-751  <0-001  0-672  0 569 to 0-792  <0 001  Germany  1-571  1-000 to 2-468  0 050  0-017  0 014 to 0-022  <0 001  USA  1 806  1 648 to 1-979  <0-001  0 087  0 083 to 0-092  <0-001 and standardised using Poisson regression modelling with the EGRET statistical package. Although the increases seen in the number of registered deaths from CFA may reflect a true increase in mortality, they could also be the result of changes in diagnostic labellingeither by the physician assigning the cause of death for a patient or during subsequent coding of the cause given on the death certificate. The accuracy of death certificate coding has been investigated for England and Wales and the specificity of CFA mortality coding found to be high at 83%. However, a substantial proportion of deaths (45%) coded as PIF were also found to meet diagnostic criteria for CFA. Thus it is possible that decreasing use ofthe less specific PIF code over time, with an increase in the use of the specific code for CFA, may explain the rises seen in CFA mortality rates. If such diagnostic transfer were an important factor then PIF mortality should have fallen over time, or at least the ratio of CFA to PIF mortality should have increased. However, in the four countries in which an increase in CFA mortality occurred, simultaneous increases were seen in PIF mortality and annual changes in the ratio of CFA to PIF deaths were small. Thus, it appears unlikely that diagnostic transfer was a major contributor to the increase in CFA mortality in these countries.
Changes to the actual practice of coding may also influence reported mortality. In 1984 the rules in England and Wales were altered to come into line with the recommendations of the World Health Organisation, such that in cases in which an unspecified pneumonia was recorded in the first part of the death certificate the underlying cause of death was coded according to the diagnosis given in the second part. To assess the effects of this change dual coding using both sets of rules was used in 19846 and, as might be expected, the number of deaths reported as being from CFA was increased under the new rules. In conclusion, this study has shown that mortality from CFA has increased significantly in several countries since 1979 and that this trend does not appear to be due to diagnostic transfer from PIF. In the USA, however, mortality rates from CFA were low and have fallen significantly over time, and this may reflect systematic coding of CFA as PIF. The increasing importance of CFA as a cause of death and disability, together with the poor response of CFA to treatment,202' mean that it is important that the potential cause (or causes) of this disease are recognised so that steps may be taken where possible to prevent it.
